SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff and Goldman Sachs Buy upgrade are driving discussion, but the upgrade-fueled bounce quickly faded as traders focused on the companys heavy debt, borrowing costs, and ability to finance its AI infrastructure expansion. Dip buyers see an oversold setup and possible short squeeze, while bears warn of further losses or dilution if financing remains difficult.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXOs continued slide to fresh lows is dominating discussion, with traders pointing to weak housing and roofing demand, high rates, and analyst target cuts as pressures on the building-products roll-up. Many criticize perceived dilution and managements limited communication, while some long-term holders argue the selloff is excessive and continue buying.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

HOOD is drawing attention for a steep selloff, with traders pointing to analyst caution and target cuts, broader risk-off conditions, and weakness in crypto-related stocks as possible pressures ahead of earnings. The conversation is split between fears of further losses and dip-buying hopes that support will hold and the stock can recover.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention for its steep slide to new lows, with many traders criticizing the companys business fundamentals and treating it as a Trump-linked meme stock; political fortunes and the approaching midterms are also cited as potential overhangs. Some traders still frame the depressed share price and merger or fusion prospects as a speculative opportunity.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are under pressure amid scheduled IPO lockup share releases, concerns about insider selling, and a TD Cowen price-target cut; traders also debate whether valuation, growth and OpenAI customer concentration leave room for further downside. Most discussion is bearish and frustrated, though some investors see the selloff as an oversold buying opportunity based on Cerebrass AI-chip potential.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs steep, persistent selloff and weak performance despite relatively resilient Bitcoin are dominating discussion, with traders pointing to skepticism over the AI/data-center pivot and the lack of signed tenant contracts. Frustrated bears cite management and execution concerns, while some bulls view the decline as overdone and anticipate a rebound if Bitcoin strengthens or a lease is announced.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

The FDAs acceptance of CorMedixs supplemental application for REZZAYO prophylaxis with Priority Review is driving attention, putting a decision on the expanded indication on the regulatory path. Traders see potential for a broader growth opportunity, but some are frustrated that the news has not produced a stronger share-price response; approval is not assured.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

OKLOs steep decline is being discussed alongside concerns about ongoing share dilution, limited company updates, and a long path to licensing and revenue, with traders also pointing to weakness across speculative nuclear stocks. Some see the selloff as an oversold entry tied to long-term nuclear power demand, while others question the companys valuation and ability to execute.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertins Phase 3 APOLLO trial met both co-primary and all secondary endpoints in erythropoietic protoporphyria, addressing efficacy questions behind the FDAs earlier rejection; the company plans to resubmit its application. Traders are debating whether the positive data can sustain the rally, with profit-taking and selling pressure competing against bullish views and speculation about a short squeeze.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus shares are drawing attention for their steep selloff and fresh lows, with traders frequently blaming share dilution and questioning the valuation and funding needs of its capital-intensive enrichment expansion. Some see the decline as an opportunity based on long-term U.S. nuclear-fuel demand, while others remain concerned about further downside and execution risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neuronetics (STIM) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Neuronetics Q2 Earnings Call Highlights

Neuronetics Q2 Earnings Call Highlights...

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of +54.55% and +3.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations, Inc. (SI) delivered earnings and revenue surprises of 0.00% and +1.93%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Is Neuronetics Stock Soaring Monday?

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. Read the details here.read more...

Neuronetics Q1 Earnings Call Highlights

Neuronetics (NASDAQ:STIM) reported first-quarter 2026 results that management said were largely in line with expectations, as the company balanced growth in its Greenbrook clinic business with a...

Neuronetics (NASDAQ:STIM) Announces Earnings Results, Beats Estimates By $0.01 EPS

Neuronetics (NASDAQ:STIM - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates...

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of +5.88% and +0.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Rises By 16.4%

Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 10,912,723 shares, an increase of 16.4% from the March 31st total of 9,377,645 shares. Currently, 17.2% of the shares of the stock are...

Neuronetics (STIM) Projected to Post Earnings on Tuesday

Neuronetics (NASDAQ:STIM) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

Neuronetics Inc

Why Is STIM Stock Rallying 16% After-Hours? 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>The shareholder instead recommended that the company’s &nbsp;clinic business operate on a standalone basis.</li><li>Neuronetics on Monday reaffirmed its fiscal year 2026 guidance of revenue in the range of $160 million-$166 million and gross margin of 47% to 49%.&nbsp;</li><li>The company also said that Steven E. Pfanstiel will depart from his role as CFO to pursue an opportunity outside the company.</li></ul>Shares of Neuronetics Inc. (STIM) jumped as much as 16% after-hours on Monday before paring back gains after the firm’s largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives, highlighting the company’s finite resources.Jorey Chernett, who owns about 14% of the company's outstanding shares, urged the board to consider options including the sale of its Transcranial Magnetic Stimulation (TMS) business unit under which it operates treatment centers across the U.S.The shareholder instead recommended that the company’s clinic business operate on a standalone basis. According to Chernett, the company has two compelling high-quality assets with expanding total addressable markets. The company also noted that the expected synergies of combining TMS and Greenbrook in December 2024 have not materialized thus far.“Since the December 2024 acquisition, pure-play peers have dramatically outperformed STIM and now trade at substantially higher multiples,” they said, while adding that the company has only finite resources which cannot serve both distinct businesses.<h2 class="st-heading-2">CFO Exit</h2>Neuronetics on Monday reaffirmed its fiscal year 2026 guidance of revenue in the range of $160 million to $166 million and gross margin of 47% to 49%.The company also said that Steven E. Pfanstiel will depart from his role as Chief Financial Officer (CFO) to pursue an opportunity outside the company. The company is now on the lookout for a replacement for Pfanstiel, who will remain with the company through May 1.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around STIM stock jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels.<a href="https://stocktwits.com/symbol/STIM">STIM stock</a> has dropped 50% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/orgo-stock-rallies-after-hours-on-clearing-regulatory-pathway-for-pain-relief-treatment/cZJ4yLURIYY">ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

STIM Stock - Neuronetics’ largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives on Monday. 

Neuronetics’ largest independent shareholder called upon its board of directors to conduct a review of strategic alternatives on Monday. 


iShares Russell 2000 ETF

Vanguard Total Stock Market ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$1.92
Prev Close	$1.89
Open	$1.89
Dividend Yield	0.00%
50-Day Moving Average	$2.69
Beta	1.74
Avg. Volume	1.27M
PE Ratio	-4.28

52-Week High	$3.44
52-Week Low	$0.80
Market Capitalization	$143.63M
EPS (Annual)	-$0.5913
Price to Book	8.05
Revenue Per Employee	$226,682.37

Feed

News

Sentiment

Earnings

Fundamentals

Info

STIM Fundamentals